Open Access

Chloride-liberal fluids are associated with acute kidney injury after liver transplantation

  • Ashraf Nadeem1,
  • Nawal Salahuddin1Email author,
  • Alyaa El Hazmi2,
  • Mini Joseph1,
  • Balsam Bohlega1,
  • Hend Sallam3,
  • Yasser Sheikh3 and
  • Dieter Broering3
Critical Care201418:625

https://doi.org/10.1186/s13054-014-0625-7

Received: 10 June 2014

Accepted: 28 October 2014

Published: 19 November 2014

Abstract

Introduction

Acute kidney injury (AKI) occurs frequently after liver transplantation and is associated with significant morbidity and mortality. Recent evidence has linked the predominant usage of `chloride-liberal’ intravenous fluids, such as 0.9% saline to the development of renal dysfunction in general critically ill patients. We compared the effects of perioperative fluid types on AKI in liver transplant recipients.

Methods

An observational analysis of liver transplant recipients over a 33-month period, between January 2010 and September 2013, was performed. Intensive care unit database and patient records were analyzed for determinants of early postoperative AKI. Univariate and multivariate regression analysis was carried out using a two-tailed P value less than 0.05 to establish significance. The institutional Research Ethics Committee approved the study methodology (RAC no. 2131 073).

Results

One hundred and fifty-eight liver transplants were performed, AKI developed in 57 (36.1%) patients: 39 (68.4%) fully recovered, 13 (22.8%) developed chronic renal failure and 10 (17.5%) required long-term hemodialysis. On univariate regression analysis, AKI was significantly associated with greater than 3,200 ml of chloride-liberal fluids infused within the first postoperative day (HR 5.9, 95% CI 2.64, 13.2, P <0.001), greater than 1,500 ml colloids received in the operating room (hazard ratio (HR) 1.97, 95% CI 1.01, 3.8, P = 0.046), vasopressor requirement for 48 hours posttransplant (HR 3.34, 95% CI 1.55, 7.21, P = 0.002), hyperchloremia at day 2 (HR 1.09, 95% CI 1.01, 1.18, P = 0.015) and preoperative model for end-stage liver disease (MELD) score (HR 1.08, 95% CI 1.03, 1.13, P <0.001).

After stepwise multivariate regression, infusion of greater than 3,200 ml of chloride-liberal fluids (HR 6.25, 95% CI 2.69, 14.5, P <0.000) and preoperative MELD score (HR 1.08, 95% CI 1.02, 1.15, P = 0.004) remained significant predictors for AKI.

Conclusions

In a sample of liver transplant recipients, infusion of higher volumes of chloride-liberal fluids and preoperative status was associated with an increased risk for postoperative AKI.

Introduction

Acute kidney injury (AKI) occurs both frequently after liver transplantation, reportedly in 29 to 60% recipients [1]-[3] and, irrespective of severity, confers an increased risk of death [4]. This increase in risk of mortality extends from the early postoperative period (28 days) and up to one year after transplantation [1]. The National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) long-term follow-up study ascribed a 2.66 hazard ratio (HR) directly attributable to renal dysfunction developing after liver transplantation [5].

Previously described risk factors for AKI in liver recipients are greater severity of illness pretransplant (higher model for end-stage liver disease (MELD) scores, intensive care unit (ICU) admission, and coagulopathy), vasopressors, and greater transfusions in the immediate perioperative period [5]-[13]. However, very little is known about the effects of intravenous fluid selection (chloride-liberal versus chloride-restrictive) or the effects of fluid balance on the risk of renal injury. An overall fluid overload state leads to renal congestion, compromised renal blood flow and reductions in glomerular filtration rate (GFR) [14]. In critically ill patients, a positive fluid balance has been associated with increased mortality [15],[16] and poorer outcomes once AKI develops [17]-[19]. Recent evidence has highlighted the possible nephrotoxic effects of `chloride-liberal’ fluids (0.9% saline). Animal and human controlled studies have shown that infusions of chloride-liberal or solutions with supraphysiological chloride concentrations cause vasoconstriction of renal afferent arterioles, cortical hypoperfusion and decreased GFR [20]-[22]. In a recent pre- and postintervention study, restriction to chloride-restrictive fluids was associated with lower AKI and need for renal replacement therapy (RRT) as compared to chloride-liberal fluids [23]. Therefore, perioperative intravenous fluid selection and volume may prove to be a modifiable risk factor for the prevention of AKI. No similar data exists for liver transplant recipients. These patients clearly are at an increased risk of renal injury with mortal consequences. We hypothesized that AKI occurring in the early postoperative period after liver transplant may be associated with the use of chloride-liberal fluids and overall fluid overload causing renal congestion.

Material and methods

This study is reported following the STROBE statement checklist for observational studies [24]. All studies at our institution require ethical approval; the Office of Research Affairs (ORA) and ORA Research Ethics Committee approved the study (RAC no. 2131 073). Patient consent was waived by the Research Ethics Committee.

Study design and setting

This was an observational study of liver transplant recipients carried out at a tertiary care, university hospital over a 33-month period between January 2010 and September 2013.

Operational definitions

AKI was defined according to the risk, injury, failure, loss, end-stage renal failure (RIFLE) classification [25] of renal dysfunction, that is using both increases in creatinine from preoperative values and urine output measured as urine volume in milliliters/patient’s baseline weight in kilograms/hour. Serum creatinine values were measured preoperatively and daily for up to the third postoperative day. Serum creatinine was measured using the COBAS Integra Creatinine plus ver. 2 assay (Roche Diagnostics Corp, Basel, Switzerland). This is an enzymatic method based on the determination of hydrogen peroxide after conversion of creatinine with the aid of creatininase, creatinase, and sarcosine oxidase. Patients were screened for the development of postoperative AKI on a daily basis until the third day.

Prolonged ICU stay was defined a priori as a cutoff value of the mean (or median for skewed data) ICU days after transplantation. Delayed weaning from mechanical ventilation was defined as <3 > days of invasive ventilation.

Chloride-liberal fluids were fluids containing supraphysiological concentrations of chloride (0.9% saline, 20% and 5% albumin); chloride-restrictive fluids were fluids with chloride concentrations closer to plasma (0.45% saline, Ringer’s lactate).

Participants

Consecutive adult liver transplant recipients within the specified study period were included. Patients undergoing multiorgan transplantation were excluded.

Crystalloids used in the study patients were: lactated Ringer’s (sodium chloride, potassium chloride, sodium lactate and calcium chloride) injection, 0.9% sodium chloride injection, USP, 0.45% sodium chloride injection, USP, manufactured by Baxter Healthcare Corp, Deerfield IL, USA. Colloids used were: human albumin 5% and 20% manufactured by Biotest Pharma GmbH, Dreieich, Germany.

Variables

The primary outcome variable was the development of postoperative AKI. Other outcome variables studied were delayed weaning from mechanical ventilation, prolonged ICU stay (as defined above), ICU mortality, and 28-day mortality. Other variables collected were recipient demographic data, etiology of cirrhosis, comorbidities, posttransplant acute physiologic and chronic health evaluation II (APACHE II) scores, routine hematological, biochemical and organ dysfunction/physiological (AKI, vasopressors, RRT, mechanical ventilation) data, fluid balance, fluids and blood products received at admission to ICU and daily up to day 3 posttransplantation.

Data sources/measurement

In our ICU, patient data is routinely entered into an ICU database. Data entry is by a critical care nurse dedicated to the database. Patient data required for the study and missing from the database was extracted by the research team (AH, HS, BB, AN) from the patient’s electronic medical records and laboratory computerized results.

Statistical analysis

Continuous data was tested for normality: measures of central tendency were compared as means ± standard deviations (SD) using the Student’s t test for normally distributed variables and as medians (interquartile range, IQR) using the Mann-Whitney U test for skewed data. Categorical variables were compared using the chi-square test or the Fisher exact test for n <5. Fluid volumes were dealt with as continuous variables while fluid types were classified into either `chloride-liberal’ or `chloride-restrictive’ and correspondingly dealt with as continuous variables. Logistic regression analysis was performed to determine the predictive ability of variables for AKI, prolonged ICU stay and prolonged mechanical ventilation. Univariate and multivariate techniques were used, and for multivariate regression, a backward mode with a threshold 0.15 was used for elimination. Multivariate associations were reported as odds ratios (OR) with 95% confidence intervals (CIs). A two-sided P value of <0.05 was considered as statistically significant. All analyses were carried out using IBM SPSS version 22.0 (IBM Corp, Armonk, NY, USA).

Results

Participants and descriptive data

One hundred and fifty-eight liver transplants were performed during the study period. Of these, 104 (65.8%) were living donor-related transplants, 53 (33.5%) cadaveric and 1 (0.6%) was a retransplant. Mean age of transplant recipients was 52.3 ± 13.3 years and 66 (42%) were female, mean body mass index (BMI) was 26.8 ± 6 (range 14, 49). Mean MELD score at time of transplantation was 19.4 ± 7.7 (range 6, 45), with mean baseline creatinine 88.7 micromol/L ± 56 (range 27, 350). Transplant recipients had end-stage liver disease caused by: hepatitis C in 60 (38%) patients, hepatitis B in 34 (21.5%), cryptogenic liver disease in 41 (25.9%), autoimmune disease in 9 (5.7%) and others (bilharziasis, congenital hepatic cirrhosis, Budd-Chiari, Wilson’s disease) in 14 (9%) recipients. Fifty-two (32.9%) patients had hepatocellular carcinomas.

All patients were transferred to the ICU posttransplant. On arrival, transplant recipients were in a positive fluid balance of 8.48 ± 2.3 liters fluid, having received 1.7 ± 0.26 L packed red cells, 3.8 ± 0.143 L blood products (plasma, cryoprecipitate, platelets) and a mean of 7.8 ± 6.3 L crystalloids of which 5.6 ± 4.0 L were chloride-liberal and 2.4 ± 1.4 L were chloride-restrictive fluids. Mean APACHE II score was 15.9 ± 5.4 (range 4, 48), serum procalcitonin level 2.4 ngm/ml (IQR 3.1), proBNP 476 pg/mL (IQR 2,510) and 120 (76%) patients were on a norepinephrine infusion. Seventy-eight (49.4%) had pleural effusions; pleural drainage by pigtail catheters was carried out in 23 out of 78 patients (29.4%). In the first 72 hours of ICU stay, transplant recipients were in a cumulative positive fluid balance of 12.7 ± 7.8 L with 9 ± 6 L crystalloids, 6.4 ± 3.5 L colloids (5%, 20% albumin) and 25 ± 11.9 L chloride-liberal (0.9% saline, 5% albumin, 20% albumin) received. Blood products transfused were 4 L (IQR 4.8). There was no significant difference between the mean serum chloride levels in the chloride-liberal group compared to the chloride-restrictive group, 114 ± 5.8 versus 113 ± 5.9, P >0.05. No significant correlation was found between the mean serum chloride concentrations and the cumulative volumes of chloride-liberal fluids given, P >0.05 (see Table 1 and Figure 1).
Table 1

Chemical compositions of fluids used in liver transplant recipients

Fluid-type

Composition per 1 liter

Manufacturer

crystalloids

  

0.9% Sodium chloride, USP

154 mEq Sodium

Baxter Healthcare Corp, Deerfield, IL, USA

154 mEq Chloride

0.45% Sodium chloride, USP

77 mEq Sodium

Baxter Healthcare Corp, Deerfield, IL, USA

77 mEq Chloride

Lactated Ringer’s injection, USP

130 mEq Sodium

Baxter Healthcare Corp, Deerfield, IL, USA

4 mEq Potassium

3 mEq Calcium

109 mEq Chloride

28 mEq Sodium lactate

Colloids

  

Human albumin 5% biotest

Plasma protein 50gm (96% albumin), caprylate (4 mmol/l), N-acetyl-DL-tryptophanate (4 mmol/l), sodium ions (145 mmol/l), water for injections ad 1,000 ml

Biotest Pharma GmbH

Dreieich, Germany

Human albumin 20% biotest (given diluted in 0.9% normal saline)

200 g/l (at least 95% is human albumin)

Biotest Pharma GmbH

Dreieich, Germany

Figure 1

Relative volumes of chloride-liberal fluids received by liver transplant recipients with and without acute kidney injury (AKI).

Median ICU length of stay was five days (IQR 6), mean 8.4 ± 12.5 days. Patients were ventilated for a median of two days (IQR 2) with nine (5.7%) patients subsequently undergoing tracheostomy. ICU mortality was 8.2% (13 patients); 28-day survival was 140 (88.6%). Eight (5%) recipients were readmitted to the ICU for the following: respiratory failure two, sepsis three, bleeding three. Mean time to readmission was 3.5 ± 1.1 days (2, 5).

Outcomes

AKI developed in 58 (36.4%) patients; classified as risk in 30 (52%), injury in 12 (21%) and failure in 16 (27%) patients. Ninety percent (53 patients) developed AKI within the first two postoperative days. All liver transplant patients, both the group that developed AKI and those that did not were on the calcineurin inhibitor, tacrolimus. Drug levels were routinely monitored and dosing adjusted accordingly. Thirty-nine (68.4%) patients recovered fully, 13 (22.8%) developed chronic renal failure and 10 (17.5%) required long-term hemodialysis. AKI was significantly associated with ICU mortality, P = 0.001 and 28-day mortality, P <0.001. Mean serum chloride levels on the second postoperative day were significantly greater in patients who developed AKI compared to those who did not; 114 ± 7.2 versus 112 ± 4.4, P = 0.01. The mean chloride levels on days one and three were not significantly different. There were no significant associations between mean serum chloride levels and the severity of renal failure (see Table 2).
Table 2

Characteristics of liver transplant patients grouped by acute kidney injury according to the RIFLE classification

 

No AKI (n = 101)

AKI (n =57)

P value

Age , years

51 ± 14.2

54 ± 11.3

0.13

BMI

26.4 ± 6

27.7 ± 6.6

0.19

Pretransplant creatinine , micromol/L

76.2 ± 40.2

110.8 ± 72.6

0.001

Pretransplant MELD score

19.2 ± 5.4

21.8 ± 9.1

0.001

Volume of chloride-liberal fluids , liters (IQR)

   

Operating room

4.7 (5.7)

6 (6.8)

0.23

24 hours

2.1 (1.2)

3.8 (2.7)

<0.001

48 hours

0.64 (1.06)

1.7 (1.5)

0.007

72 hours

0.35 (0.65)

1.07 (0.87)

0.55

Volume of chloride-restrictive fluids , liters (IQR)

   

Operating room

2 (2)

2 (1.2)

0.46

24 hours

1.9 (1.28)

1.8 (1.4)

0.32

48 hours

2.0 (0.76)

1.9 (1.6)

0.86

72 hours

1.3 (1.0)

1.6 (1.1)

0.67

Volume of colloids , liters (IQR)

   

Operating room

1.5 (1)

2.1 (2.5)

0.013

24 hours posttransplant

1.2 (1.03)

1.9 (1.4)

0.001

48 hours posttransplant

0.45 (0.85)

0.95 (0.71)

0.016

72 hours posttransplant

0.35 (0.65)

1.0 (0.87)

0.05

Volume of packed RBC transfusions , liters (IQR)

   

Operating room

1.5 (1.2)

2.2 (1.9)

0.022

24 hours

0.76 (0.44)

1.14 (5.8)

0.19

48 hours

0.53 (0.38)

0.72 (0.53)

0.08

72 hours

0.38 (0.71)

0.38 (0.06)

0.89

Volume of blood products transfused , liters (IQR)

   

Operating room

3.2 (2.3)

3.8 (3.2)

0.17

24 hours

0.95 (2.1)

2.1 (4.8)

0.14

48 hours posttransplant

0.72 (0.53)

0.97 (1.2)

0.63

72 hours posttransplant

0.63 (1.5)

0.51 (0.32)

0.78

Volume of crystalloids infused , liters (IQR)

   

Operating room

6 (5.6)

6 (6)

0.8

24 hours

2.5 (1.3)

3.1 (1.9)

0.15

48 hours

2.1 (0.72)

2.4 (1.4)

0.22

72 hours

1.6 (0.96)

1.7 (1.1)

0.30

Fluid balance , liters (IQR)

   

Operating room

6.4 (4.7)

6.7 (5.4)

0.76

24 hours

2.9 (2.6)

3.7 (4.8)

0.09

48 hours

1.6 (1.5)

1.7 (2.4)

0.06

72 hours

0.947 (2.07)

0.623 (1.54)

0.93

Serum lactate , mmol/L

   

Day 1

4.2 ± 2.9

4.8 ± 3.9

0.26

Day 2

1.8 ± 1.1

2.1 ± 1.6

0.09

Day 3

1.4 ± 0.5

1.9 ± 0.3

0.046

Serum sodium , mmol/L

   

Day 1

146 ± 5.2

146.5 ± 5.0

0.57

Day 2

143 ± 5.7

145 ± 3

0.016

Day 3

144 ± 2.3

146 ± 2.6

0.002

Serum chloride , mmol/L

   

Day 1

114 ± 5.7

113 ± 5.9

0.76

Day 2

112 ± 4.4

114 ± 7.2

0.01

Day 3

110 ± 4.6

111 ± 4.8

0.18

Vasopressor requirement

   

At admission

73 (72%)

47 (82.5%)

0.25

Day 1

3 (3%)

1 (1.8%)

0.64

Day 2

15 (14.8%)

21 (36.8%)

0.002

Day 3

4 (4%)

8 (14%)

0.056

Days on mechanical ventilation

2.3 ± 3.6

6 ± 7.1

0.001

Length of ICU stay after transplant

5.5 ± 4.7

13.4 ± 19

0.003

AKI, acute kidney injury; BMI, body mass index; ICU, intensive care unit; IQR, interquartile range; MELD, model for end-stage liver disease; RIFLE, risk, injury, failure, loss, end-stage renal failure.

Univariate outcome data

On univariate regression analysis, AKI was significantly associated with greater than 3,200 ml of chloride-liberal fluids infused within the first postoperative day (HR 5.9, 95% CI 2.64, 13.2, P <0.001), greater than 1,500 ml colloids received in the OR (HR 1.97, 95% CI 1.01, 3.8, P = 0.046), vasopressor requirement for 48 hours posttransplant (HR 3.34, 95% CI 1.55, 7.21, P = 0.002), hyperchloremia at day 2 (HR 1.09, 95% CI 1.01, 1.18, P = 0.015) and preoperative MELD score (HR 1.08, 95% CI 1.03, 1.13, P = 0.001).

Delayed weaning from mechanical ventilation was associated with higher volumes of chloride-liberal fluids, P = 0.02, higher colloid volumes, P = 0.015, blood products transfused, P = 0.017 and a cumulative positive fluid balance, P = 0.026. Higher pretransplant MELD scores, P = 0.001, male gender, P = 0.015, transplant for hepatocellular carcinoma, P = 0.014, crystalloid volume received in the first 72 hours, P = 0.034, need for vasopressors at 48 hours, P <0.001 and 72 hours, P = 0.031, AKI, P <0.001 and pleural effusion, P = 0.001 were significantly associated with a prolonged ICU admission. Drainage of effusion was significantly associated with a reduced ICU stay, P = 0.007 (see Tables 3 and 4).
Table 3

Demographic, fluids and outcome variables in liver transplant patients grouped by ICU length of stay

 

<5 days ICU stay (n = 78)

≥5 days ICU stay (n = 80)

P value

Male gender

25 (32%)

41 (51.2%)

0.015

HCC

33 (42.3%)

19 (23.1.7%)

0.014

Pretransplant MELD score

17 ± 5.9

21.3 ± 8

0.001

Volume of crystalloids received by 72 hours ml (IQR)

1,675 (1,055)

1,520 (1,066)

0.034

Volume of colloids received by ml (IQR)

   

24 hours posttransplant

1,247 (1,263)

1,700 (1,188)

0.046

48 hours posttransplant

650 (713)

950 (1095)

0.015

Undrained pleural effusion posttransplant

28 (35.8%)

50 (62.5%)

0.001

Vasopressors requirement

   

48 hours posttransplant

8 (10.3%)

28 (35%)

0.001

72 hours posttransplant

2 (2.6%)

10 (12.5%)

0.031

AKI

17 (22%)

40 (50%)

<0.001

Early complications

43 (55.1%)

50 (62.5%)

0.035

AKI, acute kidney injury; HCC, hepatocellular carcinoma; ICU, intensive care unit; IQR, interquartile range; MELD, model for end-stage liver disease.

Table 4

Perioperative fluids in patients after liver transplant grouped by delayed weaning from mechanical ventilation

 

<3 days mechanical ventilation (n = 104)

≥3 days mechanical ventilation (n = 54)

P value

Volume of blood products , * ml (IQR)

   

Operating room

4,030 (2391)

5,321 (4607)

0.015

24 hours posttransplant

920 (1551)

3,028 (3893)

0.017

48 hours posttransplant

415 (470)

827 (1194)

0.048

Volume of colloids , ml (IQR)

   

Operating room

1,500 (1875)

2,421 (850)

0.032

24 hours posttransplant

1,842 (1019)

2,315 (1205)

<0.001

48 hours posttransplant

625 (669)

1,193 (933)

<0.001

72 hours posttransplant

675 (881)

700 (883)

0.015

Volume of chloride-liberal fluids , ml (IQR)

   

Operating room

5,000 (7813)

7,000 (8434)

0.027

24 hours posttransplant

3,397 (2868)

3,725 (2473)

0.020

Fluid balance at 48 hours posttransplant , ml

1,725 (1186)

2,257 (2102)

0.026

*Includes packed cells, fresh frozen plasma, platelets, cryoprecipitate. IQR, interquartile range.

Multivariate analysis

After adjusting for covariates, infusion of greater than 3,200 ml of chloride-liberal fluids (HR 6.25, 95% CI 2.69, 14.5, P <0.001) and preoperative MELD score (HR 1.08, 95% CI 1.02, 1.15, P = 0.004) remained significant predictors for AKI. Prolonged ICU stay was predicted by male gender, P = 0.014, vasopressors = 0.003 and the development of AKI, P = 0.013 (see Table 5).
Table 5

Regression analysis for variables associated with acute kidney injury post-liver transplantation

 

Hazard ratio

95% CI

P value

Univariate analysis

   

MELD score

1.08

1.03,1013

0.001

APACHE II score at admission to ICU

1.08

1.03,1.15

0.018

Colloids ≥1,500 ml received in OR

1.97

1.01,3.8

0.046

Chloride-liberal fluids ≥3,200 ml received within the first 24 hours posttransplant

5.9

2.64,13.2

0.000

Vasopressors requirement at 2 days posttransplant

3.34

1.55,7.21

0.002

Serum chloride level at day 2

1.09

1.01,1.18

0.015

Multivariate analysis

   

Chloride-liberal fluids ≥3,200 ml received within the first 24 hours posttransplant

6.25

2.69,14.5

<0.001

Preoperative MELD score

1.08

1.02,1.15

0.004

APACHE II, acute physiology and chronic health evaluation II; CI, confidence interval; ICU, intensive care unit; MELD, model for end-stage liver disease; OR, operating room.

Discussion

In this observational study, we found that liver transplant recipients were more likely to develop AKI if they received larger volumes of chloride-liberal (hyperchloremic) fluids. This association was significant, after adjusting for baseline variables, for both 5% albumin in 0.9% saline and only 0.9% saline infusions. Patients who developed AKI had significantly higher serum chloride levels compared to transplant recipients that did not develop AKI.

`Normal’ saline or 0.9% saline contains supraphysiological levels of chloride (154 mmol/L as compared to Hartmann’s solution, Ringer’s lactate or Plasma-Lyte 148, all of which contain chloride concentrations that are lower (94 to 111 mmol/L). Five percent albumin is available either as salt-poor or in sodium chloride (chloride concentration 128 mmol/L). Intravenous infusions of chloride-liberal fluids have been associated with hyperchloremia and metabolic acidosis when administered in large volumes [26].

Our results show a detrimental effect on renal function with use of chloride-liberal fluids in the immediate postoperative period (up to 48 hours). Support for our findings comes from animal studies that have demonstrated reductions in GFRs, renal arteriolar vasoconstriction [27], and human volunteer studies that have shown reduced renal cortical tissue perfusion, renal blood flow velocity after infusions of hyperchloremic solutions. [28]. In controlled trials, chloride-liberal fluids compared to chloride-poor fluids have been linked to longer time to micturition [21], lower urine output [29] and in a recent observational study of over 31,000 postoperative patients, 0.9% saline compared to `balanced’ crystalloids increased the risk of acute renal failure requiring dialysis [30]. Yunos et al., in a pre- and postintervention study on 1,530 critically ill patients found that a chloride-restrictive fluid strategy resulted in a significant reduction in AKI, need for RRT and increase in creatinine as compared to a control group given chloride-liberal fluids [23].

Possible explanations for this renal `toxicity’ of chloride-liberal fluids come from animal studies that have demonstrated renal vasoconstriction [22] and thromboxane release after chloride infusions [20]. Chloride infusions increase delivery to the macula densa that stimulates glomerulotubular feedback leading to afferent arteriole constriction, mesangial contraction and resultant decrease in GFR [31].

Patients in our study received both 5% albumin in saline and 20% albumin in saline. Though it is possible that the observed renal dysfunction resulted from hyperoncotic albumin, the data on 20% albumin is so far inconclusive. A recent cohort study on 1,000 patients found a higher risk of renal injury and failure with the use of hyperoncotic albumin (OR 5.99) [32], however, a contradictory result was reported from two meta-analyses that concluded no harmful effects of hyperoncotic resuscitation [33],[34]. The SAFE study that compared albumin and saline found no difference in adverse outcomes [35].

Fluid overload leads to organ dysfunction due to interstitial edema and visceromegaly. The limited accommodative capacity of the encapsulated kidney causes increased interstitial hydrostatic pressures with reduced renal perfusion and filtration [36]. Additionally, a fluid overload state contributes to third spacing, ascitic fluid accumulation and abdominal compartment syndrome [37]. Cumulative fluid overload has been linked to poor outcomes in all groups (pediatric, septic, postoperative) of critically ill patients with prolonged days on mechanical ventilation, ICU stay and mortality [16],[17],[38]-[43]. Recovery of renal function in patients on RRT is also determined by overall fluid balance [17],[38],[42]. In our study, a cumulative positive fluid balance increased the duration of stay in ICU.

A limitation of our study is that the observational design does not establish a causal relationship of hyperchloremic fluid excess with the development of AKI in liver transplant recipients. These associations may be subject to bias from selection, confounding or random error. We attempted to control for confounders by using regression analysis. Another limitation is the external validity or generalizability of our results to other liver transplant recipients since we collected data only from a single institution.

Conclusions

In summary, large infusions of chloride-liberal fluids may predict a higher risk of AKI in liver transplant recipients. Our findings support the hypothesis that `routine’ intravenous fluids may not be routine and in themselves be associated with organ dysfunction. Our results can be used to build hypotheses for further controlled trials.

Key messages

Chloride-liberal fluids may cause renal dysfunction

Large volumes (>3,200 ml) of chloride-liberal fluids infused in the first 24 hours after liver transplantation were associated with a higher risk of AKI.

Authors’ contributions

AN participated in the design of the study, collected the data, analyzed and interpreted the data, drafted the manuscript, and revised the manuscript critically for important intellectual content. NS conceived the study, participated in the design of the study, made the figures and table, analyzed and interpreted the data, drafted the manuscript, and revised the manuscript critically for important intellectual content. AH, MJ, HAS and BB participated in the design of the study, collected the data, and participated in the coordination of the study. YS and DB participated in the design and coordination of the study and participated in the critical review of the final manuscript. All authors have given final approval of the version to be published.

Abbreviations

AKI: 

acute kidney injury

APACHE II: 

acute physiologic and chronic health evaluation II

BMI: 

body mass index

CI: 

confidence interval

GFR: 

glomerular filtration rate

HR: 

hazard ratio

ICU: 

intensive care unit

IQR: 

interquartile range

MELD: 

model for end-stage liver disease

OR: 

odds ratio

RIFLE: 

risk, injury, failure, loss, end-stage renal failure

RRT: 

renal replacement therapy

SD: 

standard deviation

Declarations

Acknowledgements

There was no special funding for the study. The design, collection, analysis and interpretation of data, plus writing and publication of the manuscript were done by the authors without participation or influence from any of the funding sources.

Authors’ Affiliations

(1)
Department of Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, At Takhassusi, Al Madhar Ash Shamali
(2)
Department of Nursing Services, King Faisal Specialist Hospital and Research Centre, At Takhassusi, Al Madhar Ash Shamali
(3)
Organ transplant Centre, King Faisal Specialist Hospital and Research Centre, At Takhassusi, Al Madhar Ash Shamali

References

  1. Zhu M, Li Y, Xia Q, Wang S, Qiu Y, Che M, Dai H, Qian J, Ni Z, Axelsson J, Yan Y: Strong impact of acute kidney injury on survival after liver transplantation. Transplant Proc. 2010, 42: 3634-3638. 10.1016/j.transproceed.2010.08.059.View ArticleGoogle Scholar
  2. Karapanagiotou A, Kydona C, Dimitriadis C, Sgourou K, Giasnetsova T, Fouzas I, Imvrios G, Gritsi-Gerogianni N: Acute kidney injury after orthotopic liver transplantation. Transplant Proc. 2012, 44: 2727-2729. 10.1016/j.transproceed.2012.09.096.View ArticleGoogle Scholar
  3. O'Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ: Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant. 2007, 7: 168-176. 10.1111/j.1600-6143.2006.01602.x.View ArticleGoogle Scholar
  4. Barri YM, Sanchez EQ, Jennings LW, Melton LB, Hays S, Levy MF, Klintmalm GB: Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl. 2009, 15: 475-483. 10.1002/lt.21682.View ArticleGoogle Scholar
  5. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR: Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010, 10: 1420-1427. 10.1111/j.1600-6143.2010.03126.x.View ArticleGoogle Scholar
  6. Wei Y, Zhang L, Lin H, Li J, Li B, Yan L, Wen T, Zeng Y, Lu S: Factors related to post-liver transplantation acute renal failure. Transplant Proc. 2006, 38: 2982-2984. 10.1016/j.transproceed.2006.08.156.View ArticleGoogle Scholar
  7. Pawarode A, Fine DM, Thuluvath PJ: Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl. 2003, 9: 741-747. 10.1053/jlts.2003.50113.View ArticleGoogle Scholar
  8. Chen J, Singhapricha T, Hu KQ, Hong JC, Steadman RH, Busuttil RW, Xia VW: Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study. Transplantation. 2011, 91: 348-353. 10.1097/TP.0b013e31820437da.View ArticleGoogle Scholar
  9. Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR, Melton LB, Saracino G, Klintmalm GB: Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation. 2004, 78: 1048-1054. 10.1097/01.TP.0000137176.95730.5B.View ArticleGoogle Scholar
  10. Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C: Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transpl. 1998, 12: 123-129.Google Scholar
  11. Lima EQ, Zanetta DM, Castro I, Massarollo PC, Mies S, Machado MM, Yu L: Risk factors for development of acute renal failure after liver transplantation. Ren Fail. 2003, 25: 553-560. 10.1081/JDI-120022546.View ArticleGoogle Scholar
  12. Lebron Gallardo M, Herrera Gutierrez ME, Seller Perez G, Curiel Balsera E, Fernandez Ortega JF, Quesada Garcia G: Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transpl. 2004, 10: 1379-1385. 10.1002/lt.20215.View ArticleGoogle Scholar
  13. Cabezuelo JB, Ramirez P, Rios A, Acosta F, Torres D, Sansano T, Pons JA, Bru M, Montoya M, Bueno FS, Robles R, Parrilla P: Risk factors of acute renal failure after liver transplantation. Kidney Int. 2006, 69: 1073-1080. 10.1038/sj.ki.5000216.View ArticleGoogle Scholar
  14. Herrler T, Tischer A, Meyer A, Feiler S, Guba M, Nowak S, Rentsch M, Bartenstein P, Hacker M, Jauch KW: The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation. 2010, 89: 40-46. 10.1097/TP.0b013e3181c40aba.View ArticleGoogle Scholar
  15. Alsous F, Khamiees M, DeGirolamo A, Amoateng-Adjepong Y, Manthous CA: Negative fluid balance predicts survival in patients with septic shock: a retrospective pilot study. Chest. 2000, 117: 1749-1754. 10.1378/chest.117.6.1749.View ArticleGoogle Scholar
  16. Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL: A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008, 12: R74-10.1186/cc6916.View ArticleGoogle Scholar
  17. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL: Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009, 76: 422-427. 10.1038/ki.2009.159.View ArticleGoogle Scholar
  18. Bagshaw SM, Brophy PD, Cruz D, Ronco C: Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care. 2008, 12: 169-10.1186/cc6948.View ArticleGoogle Scholar
  19. Reydellet L, Blasco V, Mercier MF, Antonini F, Nafati C, Harti-Souab K, Leone M, Albanese J: Impact of a goal-directed therapy protocol on postoperative fluid balance in patients undergoing liver transplantation: A retrospective study. Ann Fr Anesth Reanim. 2014, 33: e47-e54. 10.1016/j.annfar.2013.12.016.View ArticleGoogle Scholar
  20. Bullivant EM, Wilcox CS, Welch WJ: Intrarenal vasoconstriction during hyperchloremia: role of thromboxane. Am J Physiol. 1989, 256: F152-F157.Google Scholar
  21. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ: The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 1999, 88: 999-1003.Google Scholar
  22. Wilcox CS: Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983, 71: 726-735. 10.1172/JCI110820.View ArticleGoogle Scholar
  23. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M: Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012, 308: 1566-1572. 10.1001/jama.2012.13356.View ArticleGoogle Scholar
  24. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007, 335: 806-808. 10.1136/bmj.39335.541782.AD.View ArticleGoogle Scholar
  25. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004, 8: R204-R212. 10.1186/cc2872.View ArticleGoogle Scholar
  26. Wakim KG: “Normal” 0.9 per cent salt solution is neither “normal” nor physiological. JAMA. 1970, 214: 1710-10.1001/jama.1970.03180090074027.View ArticleGoogle Scholar
  27. Wan L, Bellomo R, May CN: Bolus hypertonic or normal saline resuscitation in gram-negative sepsis: systemic and regional haemodynamic effects in sheep. Crit Care Resusc. 2011, 13: 262-270.Google Scholar
  28. Chowdhury AH, Cox EF, Francis ST, Lobo DN: A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012, 256: 18-24. 10.1097/SLA.0b013e318256be72.View ArticleGoogle Scholar
  29. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG: The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid–base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001, 93: 811-816. 10.1097/00000539-200110000-00003.View ArticleGoogle Scholar
  30. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA: Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012, 255: 821-829. 10.1097/SLA.0b013e31825074f5.View ArticleGoogle Scholar
  31. Salomonsson M, Gonzalez E, Kornfeld M, Persson AE: The cytosolic chloride concentration in macula densa and cortical thick ascending limb cells. Acta Physiol Scand. 1993, 147: 305-313. 10.1111/j.1748-1716.1993.tb09503.x.View ArticleGoogle Scholar
  32. Schortgen F, Girou E, Deye N, Brochard L: The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med. 2008, 34: 2157-2168. 10.1007/s00134-008-1225-2.View ArticleGoogle Scholar
  33. Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M: Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care. 2010, 14: R191-10.1186/cc9308.View ArticleGoogle Scholar
  34. Jacob M, Chappell D, Conzen P, Wilkes MM, Becker BF, Rehm M: Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care. 2008, 12: R34-10.1186/cc6812.View ArticleGoogle Scholar
  35. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004, 350: 2247-2256. 10.1056/NEJMoa040232.View ArticleGoogle Scholar
  36. Stone HH, Fulenwider JT: Renal decapsulation in the prevention of post-ischemic oliguria. Ann Surg. 1977, 186: 343-355. 10.1097/00000658-197709000-00012.View ArticleGoogle Scholar
  37. Vidal MG, Ruiz Weisser J, Gonzalez F, Toro MA, Loudet C, Balasini C, Canales H, Reina R, Estenssoro E: Incidence and clinical effects of intra-abdominal hypertension in critically ill patients. Crit Care Med. 2008, 36: 1823-1831. 10.1097/CCM.0b013e31817c7a4d.View ArticleGoogle Scholar
  38. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J, Lo S, McArthur C, McGuiness S, Norton R, Myburgh J, Scheinkestel C, Su S: An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs Augmented Level of Replacement Therapy trial. Crit Care Med. 2012, 40: 1753-1760. 10.1097/CCM.0b013e318255d9a0.View ArticleGoogle Scholar
  39. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA: Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011, 39: 259-265. 10.1097/CCM.0b013e3181feeb15.View ArticleGoogle Scholar
  40. Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen PE, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F: Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003, 238: 641-648. 10.1097/01.sla.0000094387.50865.23.View ArticleGoogle Scholar
  41. Gillespie RS, Seidel K, Symons JM: Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol. 2004, 19: 1394-1399. 10.1007/s00467-004-1655-1.View ArticleGoogle Scholar
  42. Heung M, Wolfgram DF, Kommareddi M, Hu Y, Song PX, Ojo AO: Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrol Dial Transplant. 2012, 27: 956-961. 10.1093/ndt/gfr470.View ArticleGoogle Scholar
  43. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006, 354: 2564-2575. 10.1056/NEJMoa062200.View ArticleGoogle Scholar

Copyright

© Nadeem et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.